SS&C's Record Quarter: Riding the GLP-1 Wave and Doubling Down on AI and Tokenization
Organic growth accelerates to 7.6% amid large license renewals, as the company positions for digital assets and healthcare's next catalyst.
SSNC · Earnings Call · 2026-07-23
Record Quarter Against a Choppy Backdrop
SS&C Technologies delivered a record second quarter, with revenue up 10.3% to $1.697B and adjusted EPS of $1.76, an 18% increase. Organic growth hit 7.6%, well above guidance, driven by large license renewals and a resilient demand environment. As Bill Stone explained, "We get those license renewals when the contract runs out... it creates somewhat of a rush on revenue." (inline quote from current). The company also returned $499M to shareholders, including a record buyback, underscoring confidence in cash generation. This builds on prior momentum; in the last quarter, Bill highlighted AUA growth: "we grew AUA by $581 billion since 2024" (prior quote). The diversified model continues to shine, even with macro headwinds.The GLP-1 Catalyst and Healthcare Traction
The most headline-worthy development is the Medicare GLP-1 Bridge Program, which launched July 1. Bill commented, "We get in excess of double of the $0.20" (inline), referencing the per-claim revenue. Already processing nearly 3 million claims through DomaniRx, this program could be a significant revenue contributor if extended. This is a turnaround from prior lumpiness, as Bill once said, "I think that healthcare is a long-term play" (prior quote). The company's technology scale is proving critical for innovative health programs.Same thing as you read about tokenization... We spent $1 billion and we bought Calastone. We didn't buy Calastone so that we could be an also ran.